Correlations of total cholesterol content of erythrocyte membranes with plasma cholesterol efflux capacity

被引:0
|
作者
Wu, Mengzuo [1 ]
Zhang, Jianhua [1 ,2 ]
Xu, Yan [1 ]
Wang, Yueguo [1 ]
Deng, Fengfeng [1 ]
Chen, Xuhua [1 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiol, Hefei, Anhui, Peoples R China
[2] Jinan Univ, Dept Cardiol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
来源
BIOMEDICAL RESEARCH-INDIA | 2017年 / 28卷 / 10期
基金
中国博士后科学基金;
关键词
Total cholesterol content of erythrocyte membranes; Plasma cholesterol efflux capacity; Coronary heart disease; Acute coronary syndrome; ApoA-I; HIGH-DENSITY-LIPOPROTEIN; HDL CHOLESTEROL; ATHEROSCLEROTIC LESIONS; HIGH-RISK; CORONARY; VULNERABILITY; PROGRESSION; NIACIN;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The study aimed to detect the total cholesterol Content of Erythrocyte Membranes (CEM) and plasma Cholesterol Efflux Capacity (CEC), and to analyse its correlations with Acute Coronary Syndrome (ACS), in attempt to explore the possible causes of increasing CEM in patients. One hundred and forty-seven patients with Coronary Heart Disease (CHD) were enrolled, while 53 subjects with normal coronary arteriography served as the control group. CEM, CEC, and conventional blood lipid parameters were detected. CEM in the CHD group (138.63 +/- 34.92 mu g/mg) was significantly higher than the control group (121.29 +/- 24.04 mu g/mg) (P < 0.001). Further analysis revealed that CEM in ACS patients was significantly higher than that in the SAP (Stable Angina Pectoris) group (P< 0.001). CEC in the CHD group (1.53 +/- 0.40) was significantly lower than the control group (1.67 +/- 0.47) (P = 0.029). CEC and CEM showed a significant negative correlation (r=-0.257, P < 0.001), suggesting that the reduction of CEC might result in an increase in CEM in ACS patients.
引用
收藏
页码:4305 / 4310
页数:6
相关论文
共 50 条
  • [1] Sphingomyelin in erythrocyte membranes increases the total cholesterol content of erythrocyte membranes in patients with acute coronary syndrome
    Zhang, Jianhua
    Tu, Kexiang
    Xu, Yan
    Pan, Lingxin
    Wu, Changhao
    Chen, Xuhua
    Wu, Mengzuo
    Cheng, Ziping
    Chen, Bin
    CORONARY ARTERY DISEASE, 2013, 24 (05) : 361 - 367
  • [2] Significance of the cholesterol content of erythrocyte membranes in atherosclerosis
    Tziakas, Dimitrios N.
    Chalikias, Georgios K.
    Boudoulas, Harisios
    CLINICAL LIPIDOLOGY, 2010, 5 (04) : 449 - 452
  • [3] Cholesterol content of erythrocyte membranes and elusive target
    Pavlaki, Maria
    Kourkouli, Adriani
    Chalikias, George
    Kikas, Petros
    Tziakas, Dimitrios
    THROMBOSIS RESEARCH, 2020, 185 : 32 - 32
  • [4] Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease
    Norimatsu, Kenji
    Kuwano, Takashi
    Miura, Shin-ichiro
    Shimizu, Tomohiko
    Shiga, Yuhei
    Suematsu, Yasunori
    Miyase, Yuiko
    Adachi, Sen
    Nakamura, Ayumi
    Imaizumi, Satoshi
    Iwata, Atsushi
    Nishikawa, Hiroaki
    Uehara, Yoshinari
    Saku, Keijiro
    HEART AND VESSELS, 2017, 32 (01) : 30 - 38
  • [5] Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease
    Kenji Norimatsu
    Takashi Kuwano
    Shin-ichiro Miura
    Tomohiko Shimizu
    Yuhei Shiga
    Yasunori Suematsu
    Yuiko Miyase
    Sen Adachi
    Ayumi Nakamura
    Satoshi Imaizumi
    Atsushi Iwata
    Hiroaki Nishikawa
    Yoshinari Uehara
    Keijiro Saku
    Heart and Vessels, 2017, 32 : 30 - 38
  • [6] Total cholesterol content of erythrocyte membranes are associated with the presence of acute coronary syndrome
    Zhang, J.
    Xu, Yan
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0A) : S5 - S5
  • [7] The replacement of cholesterol by phytosterols and the increase of total sterol content in model erythrocyte membranes
    Hac-Wydro, Katarzyna
    CHEMISTRY AND PHYSICS OF LIPIDS, 2010, 163 (07) : 689 - 697
  • [8] HDL cholesterol may participate in cholesterol efflux from erythrocyte membranes - A novel atheroprotective mechanism
    Tziakas, D. N.
    Kaski, J. C.
    Chalikias, G. K.
    Romero, C.
    Fredericks, S.
    Tentes, I. K.
    Kortsaris, A. X.
    Hatseras, D. I.
    Holt, D. W.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 533 - 533
  • [9] CSL112 Increases Plasma Cholesterol Efflux Capacity and Reduces Erythrocyte Membrane Cholesterol Content in Blood Samples from Patients with Sickle Cell Disease
    Didichenko, Svetlana
    Navdaev, Alexey
    Saxenhofer, Moritz
    Graeter, Stefanie
    Schaub, Alexander
    Rovo, Alicia
    Kato, Gregory J.
    Kingwell, Bronwyn
    BLOOD, 2022, 140 : 2528 - 2529
  • [10] Comments on: Cholesterol content of erythrocyte membranes and elusive target
    Nunes, J. Massimo
    Pretorius, Etheresia
    THROMBOSIS RESEARCH, 2020, 185 : 31 - 31